Previous 10 | Next 10 |
PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular and cardiopulmonary diseases, today announced that Chief Executive Officer Jonathan P. Mow will present a company ...
PhaseBio Pharmaceuticals (NASDAQ: PHAS ) : Q2 GAAP EPS of -$0.98 misses by $0.47 . More news on: PhaseBio Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Received FDA authorization to proceed with “VANGARD” clinical trial to assess the efficacy and safety of PB1046 in hospitalized COVID-19 patients at high risk for rapid clinical deterioration and acute respiratory distress syndrome (ARDS) and commenced dosing of patients ...
PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular and cardiopulmonary diseases, today announced that Chief Executive Officer Jonathan P. Mow and other members of th...
RumbleON (NASDAQ: RMBL ) +117% on pilot program with CarGurus. More news on: RumbleON, Inc., Verona Pharma plc, Applied DNA Sciences, Inc., Stocks on the move, , Read more ...
The first patient has been dosed in a Phase 2 clinical trial, VANGUARD , evaluating PhaseBio Pharmaceuticals' (NASDAQ: PHAS ) PB1046 in hospitalized COVID-19 patients at high risk for rapid clinical deterioration and acute respiratory distress syndrome (ARDS). More news on: PhaseBio P...
Recently launched Phase 2 “VANGARD” trial to assess the efficacy and safety of PB1046 in hospitalized COVID-19 patients at high risk for rapid clinical deterioration and acute respiratory distress syndrome PB1046, a long-acting analog of vasoactive intestinal peptide (VIP...
ARCA biopharma (NASDAQ: ABIO ) -28% . More news on: ARCA biopharma, Inc., ToughBuilt Industries, Inc., Canopy Growth Corporation, Stocks on the move, , Read more ...
Gainers: ARCA biopharma (NASDAQ: ABIO ) +174% . More news on: ARCA biopharma, Inc., Monaker Group, Inc., Triumph Group, Inc., Stocks on the move, , Read more ...
ARCA biopharma (NASDAQ: ABIO ) +59% on launching AB201 program in COVID-19. More news on: ARCA biopharma, Inc., PhaseBio Pharmaceuticals, Inc., Technical Communications Corporation, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
PhaseBio Pharmaceuticals Inc. Company Name:
PHAS Stock Symbol:
NASDAQ Market:
Bidding Process and Auction Projected to Conclude December 2022 PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular diseases, today announced that...
PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular diseases, today reported financial results for the second quarter ended June 30, 2022, and provided an upd...